SCHEMBL6775922

SCHEMBL6775922

CCOC(=O)CCN(C(=O)c1ccc2sc(CSc3ccc(C#N)cc3)nc2c1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 2/20 0.37
F2 P00734 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
NQO2 P16083 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ITK Q08881 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
ALOX5 P09917 1/20 0.34
EPHX2 P34913 1/20 0.34
PRSS12 P56730 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7169154 0.89 SMN1; SMN2 (0.37) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL6779401 0.88 F2 (0.45) KMT2AMEN1NPC1F2NQO2
Hydrochloric Acid SCHEMBL6781435 0.88 NQO2 (0.46) F2NQO2
SCHEMBL6779991 0.88 KMT2A (0.41) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL6780500 0.87 KMT2A (0.40) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL6776027 0.82 NQO2 (0.49) F2NQO2ITK
SCHEMBL6779467 0.82 SMN1; SMN2 (0.45) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL6779548 0.81 SMN1; SMN2 (0.44) KMT2AMEN1NPC1SMN1; SMN2MAPT
SCHEMBL6781181 0.80 HDAC6 (0.43) KMT2AMEN1NPC1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL7164407 0.78 TMPRSS15 (0.41) KMT2ANPC1SMN1; SMN2MAPTF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710055-B2 INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBO QUINOLINE-8-SULFONYLAMINO)-INDOLE BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2004-03-23 US disclosed
US-20030004181-A1 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-02 US disclosed
US-6469039-B1 BENZIMIDAZOLES; THROMBIN- INHIBITING ACTIVITY AND THE EFFECT OF EXTENDING THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-22 US disclosed
US-6414008-B1 CYNAO- OR AMIDINE-SUBSTITUTED BENZIMIDAZOLES, BENOTHIAZOLES, OR BENZOXAZOLES; 2-(N-(4-AMIDINOPHENYL)AMINOMETHYL)BENZOTHIAZOLES; 2-((4-CYANOPHENYL)OXYMETHYL)IMIDAZOL(4,5-B)PYRIDINES; ANTITHROMBOTICS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-07-02 US disclosed
US-6087380-A ANTITHROMBOTIC BENZIMIDAZOLES; ANTICOAGULANTS; 2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-BENZIMIDAZOL-5-YL-CARBOXYLIC ACIDS BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004181-A1 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions F2, TFPI, FGB KMT2A 2512/4885MEN1 1446/4885NPC1 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.